Emine Rana Bağci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emine Rana Bağci has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ulviye Acar Çevik
Anadolu University
3 shared publications - Abdüllatif Karakaya
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bülent Ecevit University, 67600 Zonguldak, Turkey
2 shared publications - Betül Kaya Çavuşoğlu
Bilecik Seyh Edebali University
2 shared publications - Nour El-Huda Daoud
Department of Pharmaceutical Chemistry, Faculty of Pharmacy Anadolu University Eskişehir Turkey
2 shared publications - Zafer Asım Kaplancıklı
Anadolu University
2 shared publications - Ayşen Işık
Selcuk University
1 shared publication
Latest Publications
- 16 October 2026
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 18 (21) , 3013-3031
Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors
1. Cancer is a disease caused by the uncontrolled growth and proliferation of cells [1], a secondary cause of death worldwide [2]. Although many treatment options are available today to treat the d...
- 16 October 2026
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 18 (21) , 3013-3031
Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors
1. Cancer is a disease caused by the uncontrolled growth and proliferation of cells [1], a secondary cause of death worldwide [2]. Although many treatment options are available today to treat the d...
- 31 August 2026
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 5 (2) , 53-74
Thiazole: A promising scaffold in medicinal chemistry
Thiazole, a five-membered heterocyclic skeleton found in numerous commercially marketed drugs and various natural products, has gained significant attention in the field of medicinal chemistry. Thiazole derivatives have diverse therapeutic potential, including neuroprotective, antidiabetic, antioxidant, antimicrobial, anti-inflammatory, anticancer, antihypertensive, and antitubercular activities. The unique electronic and pharmacophoric features of the thiazole ring facilitate specific interactions with various biological targets. This review covers and highlights the most recently reported studies on thiazole-based derivatives with pharmacological potential.
- 31 August 2026
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 5 (2) , 53-74
Thiazole: A promising scaffold in medicinal chemistry
Thiazole, a five-membered heterocyclic skeleton found in numerous commercially marketed drugs and various natural products, has gained significant attention in the field of medicinal chemistry. Thiazole derivatives have diverse therapeutic potential, including neuroprotective, antidiabetic, antioxidant, antimicrobial, anti-inflammatory, anticancer, antihypertensive, and antitubercular activities. The unique electronic and pharmacophoric features of the thiazole ring facilitate specific interactions with various biological targets. This review covers and highlights the most recently reported studies on thiazole-based derivatives with pharmacological potential.
- 30 October 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (3) , 531-546
Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities
In this study, a novel series of benzofuran derivatives (2a-2k) were synthesized and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 µM concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 µM, when compared to standard gallic acid (IC50= 29.48 ± 0.014 µM). Furthermore, compounds 2d (10.33%) and 2i (20.17%), showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for the designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease.
- 30 October 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (3) , 531-546
Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities
In this study, a novel series of benzofuran derivatives (2a-2k) were synthesized and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 µM concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 µM, when compared to standard gallic acid (IC50= 29.48 ± 0.014 µM). Furthermore, compounds 2d (10.33%) and 2i (20.17%), showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for the designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease.